Elfabrio to treat Fabry disease
Drug Name: Elfabrio Indications: To treat confirmed Fabry disease. Active Ingredient: Pegunigalsidase alfa-iwxj Company: Chiesi USA, Inc. Approval Date: 5/9/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761161s000lbl.pdf